New Anticoagulant Therapy as a Treatment for Pulmonary Thromboembolism in Patients During the COVID-19 Epidemic

DOAC therapy showed equal efficacy in the long-term treatment of pulmonary embolism in both study groups, regardless of whether the subjects had COVID-19 or not.

Authors

Institutions

Publication Details

Journal
Materia Socio Medica
Published
2025-01-01
DOI
https://doi.org/10.5455/msm.2025.37.144-148
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

New Anticoagulant Therapy as a Treatment for Pulmonary Thromboembolism in Patients During the COVID-19 Epidemic

Elma Kuduzović, Amar Terzimehic, Muhamed Skomorac, Lejla Hindija
Materia Socio Medica
COVID-19 Clinical Research Studies
article

New Anticoagulant Therapy as a Treatment for Pulmonary Thromboembolism in Patients During the COVID-19 Epidemic

Elma Kuduzović, Amar Terzimehic, Muhamed Skomorac, Lejla Hindija
article en

Abstract

DOAC therapy showed equal efficacy in the long-term treatment of pulmonary embolism in both study groups, regardless of whether the subjects had COVID-19 or not.

Materia Socio MedicaVol. 37(2)
University of Zenica (BA), Vetenskap I Skolan (SE)
Openalex Percentile: Top 84%
COVID-19 Clinical Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

New Anticoagulant Therapy as a Treatment for Pulmonary Thromboembolism in Patients During the COVID-19 Epidemic — Elma Kuduzović, Amar Terzimehic, et al. · Materia Socio Medica (2025) | TGRS Research Map | TGRS